Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease

Authors

Institutions

Publication Details

Journal
JAMA Cardiology
Published
2026-03-28
DOI
https://doi.org/10.1001/jamacardio.2026.0767
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease

B. Cariou, J. Kiljanski, Russell J. Wiese, Imre Pávó et al.
JAMA Cardiology
Diabetes Treatment and Management
article

Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease

B. Cariou, J. Kiljanski, Russell J. Wiese, Imre Pávó, S NISSEN, K Wolski, Stephen J. Nicholls, David D’Alessio, Govinda Weerakkody
article en

Abstract

No abstract available for this paper.
JAMA Cardiology
Centre National de la Recherche Scientifique (FR), Cleveland Clinic (US), Inserm (FR), Eli Lilly (United States) (US), Duke Medical Center (US), Institut du Thorax (FR), Monash University (AU)
Good health and well-being
Openalex Percentile: Top 4%
Diabetes Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.